|
|
 |
|
Featured Content |
|
|
Top Stories |
Ebola Outbreak Sparks EMA Review of Experimental Ebola Treatments
In response to the Ebola outbreak, EMA has started reviewing Ebola treatments in the development pipeline. More... |
|
Highlights from the CHMP September Meeting
CHMP has recommended 15 new medicines for approval and three extensions of indication. More... |
|
PharmTech Europe Marks 25 Years of Drug Development |
Past, Present and Future of Softgel Technologies
Softgels are now being recognised as one of the preferred dosage forms for the treatment of pain, eye conditions, cough and cold, as well as allergy. More... |
|
Opportunities with Softgels
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies. More... |
|
Industry News |
UPS' Pain in the Supply Chain Results
Regulations, product protection, and cost management are top concerns of supply chain decision makers. More... |
|
CALIXAR Collaborates with VirPath to Develop H1N1 Vaccine
CALIXAR and VirPath use new manufacturing techniques to create a vaccine for the pandemic flu, influenza A (H1N1), available in 2015. More... |
|
MedImmune Receives Fast Track Designation for Development of Nosocomial Pneumonia Prevention
AstraZeneca's global biologics research group, MedImmune, received FDA Fast Track designation for MEDI3902, for the prevention of nosocomial pneumonia. More... |
|
ISO Standard 14001 Enters the DIS Stage
International Organization for Standardization's environmental management standard 14001 has entered the draft stage, allowing public commentary on revisions. More... |
|
Acorda Acquires Biopharmaceutical Company Civitas Therapeutics
Acorda Therapeutics acquired Civitas Therapeutics for $525 million, giving Acorda all the rights to CVT-301, a Phase III candidate for off episodes of Parkinson’s disease. More... |
|
Catalent and Cingulate Therapeutics to Collaborate on New ADHD Formulation
Formulation will utilize Catalent’s OSDrC OptiDose multicore drug-delivery platform. More... |
|
Rx-360 Symposium Focuses on Supplier Audits and Supply Chain Security
Meeting increasing expectations and escalating regulatory requirements to protect patients. More... |
|
Shifting Trends in Oncology
Drug-development companies and contract research organizations (CROs) are now recognizing a growing need to screen drug candidates in early stage development. Oncology, as with other areas of drug discovery, is a field that is shifting rapidly. More... |
|
|
|
|
|
 |
|
|
PharmTech Europe
25th Anniversary
Pharmaceutical Technology Europe celebrates 25 years of publishing with a retrospective of drug development trends and expert insight into emerging trends.
View Special Coverage |
|
Reference Library |
Pharmaceutical Technology Outsourcing Guide
Pharmaceutical Technology Outsourcing Guide provides details behind recent partnerships, strategies for selecting an appropriate CDMO/CMO, and quality by design factors for outsourced operations. ... Click here
|
|
Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|